In Stock
Apremilast Tablets IP
Apremilast Tablets IP is an anti-inflammatory medicine used to manage psoriasis and psoriatic arthritis by regulating inflammatory activity in the body.
Product Details
Apremilast Tablets IP contains apremilast, a phosphodiesterase-4 (PDE4) inhibitor used in the management of certain inflammatory conditions, including plaque psoriasis and psoriatic arthritis. It helps regulate inflammatory signaling pathways that contribute to skin and joint symptoms.
Key Benefits
- Used in the management of plaque psoriasis
- Helps manage symptoms associated with psoriatic arthritis
- May reduce skin lesions and inflammation in appropriate patients
- Helps control excessive inflammatory activity
- Supports long-term management of chronic inflammatory conditions
How It Works
Apremilast inhibits the PDE4 enzyme, which increases intracellular cyclic AMP and helps regulate the production of inflammatory mediators. This can reduce inflammation involved in psoriasis and psoriatic arthritis.
Common Side Effects
- Diarrhea
- Nausea
- Headache
- Vomiting
- Abdominal discomfort
- Upper respiratory tract symptoms
- Fatigue
- Reduced appetite
- Weight loss
Important Information
Apremilast Tablets IP should be used under the guidance of a qualified healthcare professional. Dose adjustment may be required in patients with severe kidney impairment. Monitor for significant weight loss or persistent gastrointestinal symptoms during treatment. Mood changes, depression, or suicidal thoughts have been reported rarely; seek medical advice promptly if significant changes in mood or behavior occur. Inform your doctor about existing medical conditions and all medicines you are taking.
